The FDA has said it will seek the advice of independent advisors before it concludes its review of Eli Lilly ... % fall after hours. Lilly’s head of neuroscience, Anne White, said the ...
Eli Lilly has been unable to secure an accelerated ... Lilly's head of neuroscience R&D Anne White said the company is confident that TRAILBLAZER-ALZ 2 will back up the results of its phase ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results